Bala Mohan

CIK 00019917871 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001991787

Recent Transactions

38 trades

Disposition from Tender
Mersana Therapeutics, Inc.$MRSN
Common Stock
2026-01-06−2,927→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Units
2026-01-06−2,500→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Units
2026-01-06−1,750→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Units
2026-01-06−700→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−9,309→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−1,190→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−5,246→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−1,053→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−2,646→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−1,853→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−7,734→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−3,515→ 0 total
Sale
Mersana Therapeutics, Inc.$MRSN
Common Stock
2025-10-27$9.90/sh−77→ 2,922 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Unit
2025-10-25−250→ 0 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2025-10-25+250→ 2,999 total
Sale
Mersana Therapeutics, Inc.$MRSN
Common Stock
2025-01-16$0.58/sh−5,939→ 68,872 total
Award
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Unit
2025-01-15+62,500→ 62,500 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Unit
2025-01-15−14,583→ 43,750 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2025-01-15+14,583→ 74,811 total
Award
Mersana Therapeutics, Inc.$MRSN
Stock Option (Right to Buy)
2025-01-15+281,250→ 281,250 total
Sale
Mersana Therapeutics, Inc.$MRSN
Common Stock
2025-01-14$0.66/sh−3,253→ 60,228 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Unit
2025-01-13−8,750→ 17,500 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2025-01-13+8,750→ 63,481 total
Sale
Mersana Therapeutics, Inc.$MRSN
Common Stock
2024-10-28$1.90/sh−1,884→ 54,731 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Unit
2024-10-25−6,250→ 6,250 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2024-10-25+6,250→ 56,615 total
Sale
Mersana Therapeutics, Inc.$MRSN
Common Stock
2024-10-03$1.96/sh−5,598→ 50,365 total
Sale
Mersana Therapeutics, Inc.$MRSN
Common Stock
2024-10-02$2.00/sh−8,089→ 55,963 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Unit
2024-10-01−50,000→ 0 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2024-10-01+50,000→ 64,052 total
Sale
Mersana Therapeutics, Inc.$MRSN
Common Stock
2024-01-16$2.71/sh−3,431→ 14,052 total
Award
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Unit
2024-01-15+58,333→ 58,333 total
Award
Mersana Therapeutics, Inc.$MRSN
Stock Option (Right to Buy)
2024-01-15+262,500→ 262,500 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Unit
2024-01-13−8,750→ 26,250 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2024-01-13+8,750→ 17,483 total
Sale
Mersana Therapeutics, Inc.$MRSN
Common Stock
2023-10-26$1.13/sh−1,912→ 8,733 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Unit
2023-10-25−6,250→ 12,500 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2023-10-25+6,250→ 10,645 total

Companies

Mersana Therapeutics, Inc.
SVP, Chief Development
$MRSN

Recent Filings

Address

C/O MERSANA THERAPEUTICS, INC. 840 MEMORIAL DRIVE

CAMBRIDGE, MA, 02139

View on SEC.gov